Here, we report a multi‐institutional follow‐up study in which we employed a standardised protocol for screening IDH1‐ and IDH2‐mutant molecules in circulating free DNA (cfDNA) from patients with CS. Here, IDH2 is linked to Cowden syndrome 1.